< Back to latest news & events

Brexit

Special Report – Brand Protection Beyond Brexit

January 2020

Since the UK voted to leave the EU in 2016’s referendum, HGF has worked to ensure that Brexit will just mean ‘business as usual’ for its clients.

We conducted a survey to better understand how prepared Europe’s companies are for life after Brexit, in terms of protecting their valuable IP rights and the brand equity this adds to their business.

We consulted more than 120 companies, many of them world-leaders in their markets and industry sectors, with specific focus on the UK, Germany, France, Spain, Switzerland and The Netherlands.

The findings are revealed in our Brand Protection Beyond Brexit Report.

Among the Key findings:
  • Almost half of companies (46%) say they will change their brand protection strategy after the UK leaves the EU
  • However, a third of companies (31%) still do not know how they will register trade marks after Brexit
  • A third (33%) say Brexit will make brand protection harder
  • 61% believe it is now important to have IP advisors based in multiple European jurisdictions, with 83% saying local knowledge is the key benefit.

To read the full report click here.

If you have any queries please contact your usual HGF Trade Mark Attorney, or David Potter, Head of the HGF Trade Mark team.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

UPC stakes claim for wide-reaching long-arm jurisdiction for European patents

Fujifilm Corporation v Kodak GmbH & ors – Thomas J, Dr Thom J and Dr Parchmann J.  – UPC_CFI_355/2023 –  28 January 2025 The Düsseldorf Local Division has delivered the …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article